polycystic%20ovarian%20syndrome
POLYCYSTIC OVARIAN SYNDROME
Polycystic ovarian syndrome (PCOS) is the accumulation of underdeveloped follicles in the ovaries due to anovulation. It is is characterized by menstrual abnormalities and clinical or biochemical features of hyperandrogenism.
It results mainly from abnormal steroidogenesis that may be caused by insulin resistance leading to hyperinsulinemia.
There is increased sensitivity to androgens and the majority of women have elevated androgen levels.

Lifestyle Modification

Lifestyle Modification

  • Lifestyle modification is recommended in all PCOS patients
    • Diet modification, exercise and weight loss in obese patients all contribute to reestablishing insulin sensitivity
    • Benefits should be emphasized during preconception counseling 
  • In women with PCOS, excess body fat aggravates insulin resistance and its associated clinical consequences
  • Central obesity and high BMI have a major impact on the development of hyperinsulinemia and hyperandrogenism
  • PCOS patients with normal body habitus should be advised to continue these and to maintain their body weight within the normal range
  • PCOS patients should be informed of and screened for risk factors of cardiovascular disease (CVD): Cigarette smoking, obesity, dyslipidemia, type 2 diabetes mellitus, family history of early CVD, hypertension, and obstructive sleep apnea

Diet Modification

  • There is no particular food plan that is recommended for PCOS
  • Frequent feedings (4-6x/day) may be helpful to avoid hypoglycemia and hunger
    • Hypoglycemia can lead to cravings and poor food choices
  • To promote weight loss, diet should be modified to an intake of carbohydrates with a low glycemic index, and a reduced intake of fat and simple sugars
    • High-protein diet appears as effective as high-carbohydrate diet, as long as fat and total calories are comparable

Exercise

  • Weight reduction and exercise can help reverse the metabolic problems in PCOS by improving ovarian function and the associated hormonal aberrations
  • Decreases risk of diabetes and CVD
  • Improvement in physical fitness and reduction in body fat will assist in resumption of ovulation and increase in fertility especially in anovulatory obese women with PCOS

Weight Reduction

  • Helps lower circulating androgen levels leading to spontaneous resumption of menses
  • Improves insulin resistance in obese patients
  • It is estimated that a loss of 5-10% of body weight can restore reproductive function in 55-100% of PCOS patients within 6 months of weight-reducing program
    • Hirsutism can also improve within 6-9 months of weight loss 
  • Associated with improved pregnancy rates and decreased hirsutism, as well as improvements in glucose and lipid levels

Management for Hirsutism

  • If hirsutism is moderate and localized, it may be treated with hair removal by shaving, laser, electrolysis or depilatory creams
  • In more severe hair growth, alternative methods can be used until androgen-suppressing therapies take effect
  • Treatment is often palliative rather than curative
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
28 Apr 2018
Treatment with teriparatide increases periostin secretion, but it is unclear whether such increase facilitates the effect of the drug on bone, reports a recent study.
Jairia Dela Cruz, 03 Apr 2018
A small cohort study presented at the Royal College of Obstetricians & Gynaecologists (RCOG) World Congress 2018 has reported a 5-year diabetic ketoacidosis (DKA) incidence rate of 4.16 percent in pregnant women with type 1 diabetes mellitus (T1DM), with generally good maternal and neonatal outcomes.
24 Apr 2018
A subclinical inflammatory state resulting from increased adiposity and metabolic dysfunction appears to contribute to breast cancer pathogenesis in Asian women, a Taiwan study has found.
25 Apr 2018
Dietary glycaemic index (GI) or glycaemic load (GL) does not appear to have any significant effect on serum concentrations of inflammatory cytokines, including high-sensitivity C-reactive protein (hs-CRP), leptin, interleukin 6 (IL-6) and tumour necrosis factor α (TNF-α) in adults, reports a new study.